<DOC>
	<DOCNO>NCT02112864</DOCNO>
	<brief_summary>Post thoracotomy pain syndrome still affect 50 % patient thoracic surgery . Pathogenesis unclear grow evidence neuro inflammation may play significant role . Dexamethasone potent anti-inflammatory drug . The hypothesis study dexamethasone , give pre operatively , would help reduce incidence post thoracotomy pain syndrome 3 month surgery , reduce inflammatory response , patient undergo elective thoracic surgery include thoracic epidural analgesia .</brief_summary>
	<brief_title>Dexamethasone Reduction Post Thoracotomy Pain Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>elective thoracic surgery use thoracotomy incision thoracic epidural analgesia ASA IIII age 1875 yo contraindication thoracic epidural analgesia patient refusal patient already take cortisone dexamethasone patient chronic opioid medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>